Calculating Receptor Occupancy using TMDD Models - What has to be Considered?

Area of Science:

• Pharmacokinetics and Pharmacodynamics
• Computational Biology
• Drug Development

Background:

• Target-mediated drug disposition (TMDD) models are crucial for understanding drug-receptor interactions and predicting receptor occupancy (RO).
• RO is vital for assessing drug responses, particularly in early clinical development stages.
• Complex TMDD models may be challenging to fit due to data limitations, necessitating the use of approximations.

Purpose of the Study:

• To evaluate the accuracy of receptor occupancy (RO) estimations derived from approximate target-mediated drug disposition (TMDD) models.
• To investigate the impact of model assumptions on the precision of parameters like the Michaelis-Menten constant (KM).
• To provide insights for improving RO predictions and dose optimization in clinical drug development.

Main Methods:

• Conducted simulation studies using parameter values sourced from existing literature.
• Analyzed receptor occupancy (RO) derived from approximate TMDD models, including those using the Michaelis-Menten constant (KM).
• Assessed the influence of model assumptions on parameter accuracy and precision when fitting models to drug concentration data.

Main Results:

• Receptor occupancy (RO) derived from the Michaelis-Menten constant (KM) of approximate TMDD models may not accurately reflect true RO.
• The accuracy and precision of model parameters, such as KM, are dependent on the chosen approximate model and its underlying assumptions.
• Model assumptions, including the site of drug-receptor binding, significantly affect parameter estimation when using limited drug concentration data.

Conclusions:

• Estimating receptor occupancy (RO) using simplified models like Michaelis-Menten can lead to inaccuracies.
• Careful consideration of model assumptions is essential for reliable parameter estimation and RO prediction in drug development.
• These findings offer valuable guidance for refining model-derived RO predictions and optimizing drug dosing strategies.